Sign in Subscribe
Medical research

Frailty Emerges as Critical Concern in Systemic Sclerosis

Strategic Insights

— 1 min read

Research from Kocaeli University has revealed that frailty is a multidimensional syndrome that contributes significantly to the progression and severity of systemic sclerosis (SSc). According to the study, frailty in SSc patients is associated with adverse outcomes such as skin involvement, increased disability, physical inactivity, higher hospitalization rates, malnutrition, severe gastrointestinal symptoms, interstitial lung disease, and elevated mortality. The research suggests that early identification of frailty at its pre-frailty stage is essential and that implementing targeted preventative strategies could mitigate its impact and enhance long-term disease management and clinical outcomes for patients with SSc.

Key Takeaways:

  • Frailty is a critical concern in systemic sclerosis (SSc), marking a multidimensional syndrome characterized by diminished physiological reserve and increased vulnerability.
  • Both age-related inflamm-aging and disease-related chronic inflammation contribute to the higher prevalence of frailty in SSc patients compared to their age-matched counterparts.
  • Frailty in SSc is strongly associated with adverse outcomes, including skin involvement, increased disability, physical inactivity, higher hospitalization rates, malnutrition, severe gastrointestinal symptoms, interstitial lung disease, and elevated mortality.
  • The research posits frailty as an overlooked factor in the progression and severity of SSc.
  • Implementing targeted preventative strategies is essential to mitigate the impact of frailty on SSc and enhance long-term disease management and clinical outcomes for patients with SSc.
  • Early identification of frailty at its pre-frailty stage is critical for effective disease management and clinical outcomes.
  • Neslihan Gokcen, a researcher from Kocaeli University, emphasized the importance of addressing frailty in SSc patients.

Statistics:

  • 3(4):207-211 is the article number for "The Impact of Frailty on Disease Progression of Systemic Sclerosis: A Hypothesis" in Anti-Aging Eastern Europe.
  • 2024 is the publication year for the journal article.
  • 4 is the volume number for Anti-Aging Eastern Europe.
  • The research was published in Anti-Aging Eastern Europe, with a free version available at https://doi-org.sdpl.idm.oclc.org/10.56543/aaeeu.2024.3.4.06.
  • 3 is the edition number for the research study.

Sources:

  • The Impact of Frailty on Disease Progression of Systemic Sclerosis: A Hypothesis. Anti-Aging Eastern Europe, 2024,3(4):207-211.
  • https://doi-org.sdpl.idm.oclc.org/10.56543/aaeeu.2024.3.4.06 (free version of the journal article)
  • Health & Medicine Week. May 9, 2025; p 2159.

Read more